Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

BESPONSA™ Principal Display Panel (inotuzumab ozogamicin)

PRINCIPAL DISPLAY PANEL - 0.9 mg Vial Label

Pfizer

NDC 0008-0100-01
Rx only

BESPONSA
(inotuzumab ozogamicin)
for Injection

0.9 mg/vial

For Intravenous Infusion Only

No Preservatives

Single-dose vial.
Discard unused portion.

PRINCIPAL DISPLAY PANEL - 0.9 mg Vial Label

PRINCIPAL DISPLAY PANEL - 0.9 mg Vial Carton

Pfizer

BESPONSA
(inotuzumab ozogamicin)
for Injection

0.9 mg/vial

Each single-dose vial delivers 0.9 mg
inotuzumab ozogamicin, polysorbate 80
(0.36 mg), sodium chloride (2.16 mg),
sucrose (180 mg), and tromethamine
(8.64 mg).

PRINCIPAL DISPLAY PANEL - 0.9 mg Vial Carton
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event